Testing for association of the monoamine oxidase a promoter polymorphism with brain structure volumes in both autism and the fragile X syndrome

Journal of Neurodevelopmental Disorders

Volumn 6, Issue 1, 2014, Pages

  Wassink, Thomas H ^a   Hazlett, Heather C ^b   Davis, Lea K ^c   Reiss, Allan L ^d   Piven, Joseph ^b  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Autism; Brain structure; Fragile X syndrome; Monoamine oxidase A; Polymorphism

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A;

ALLELE; ARTICLE; AUTISM; BIOLOGICAL TRAIT; BRAIN CORTEX; BRAIN SIZE; CAUCASIAN; CEREBROSPINAL FLUID; CHILD; CLINICAL ARTICLE; FRAGILE X SYNDROME; FRONTAL LOBE; GENE; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; GRAY MATTER; HEREDITY; HUMAN; LATERAL BRAIN VENTRICLE; LONGITUDINAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; WHITE MATTER;

EID: 84899758890     PISSN: 18661947     EISSN: 18661955     Source Type: Journal    
DOI: 10.1186/1866-1955-6-6     Document Type: Article

References (62)

1. Abdelmoity AT, LePichon JB, Nyp SS, Soden SE, Daniel CA, Yu S: 15q11.2 proximal imbalances associated with a diverse array of neuropsychiatric disorders and mild dysmorphic features. J Dev Behav Pediatr 2012, 33:570-576.
2. Zufferey F, Sherr EH, Beckmann ND, Hanson E, Maillard AM, Hippolyte L, Mace A, Ferrari C, Kutalik Z, Andrieux J, Aylward E, Barker M, Bernier R, Bouquillon S, Conus P, Delobel B, Faucett WA, Goin-Kochel RP, Grant E, Harewood L, Hunter JV, Lebon S, Ledbetter DH, Martin CL, Mannik K, Martinet D, Mukherjee P, Ramocki MB, Spence SJ, Steinman KJ, et al: A 600 kb deletion syndrome at 16p11.2 leads to energy imbalance and neuropsychiatric disorders. J Med Genet 2012, 49:660-668.
3. Wexler NS, Lorimer J, Porter J, Gomez F, Moskowitz C, Shackell E, Marder K, Penchaszadeh G, Roberts SA, Gayan J, Brocklebank D, Cherny SS, Cardon LR, Gray J, Dlouhy SR, Wiktorski S, Hodes ME, Conneally PM, Penney JB, Gusella J, Cha JH, Irizarry M, Rosas D, Hersch S, Hollingsworth Z, MacDonald M, Young AB, Andresen JM, Housman DE, De Young MM, et al: Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington's disease age of onset. Proc Natl Acad Sci U S A 2004, 101:3498-3503. (Pubitemid 38338224)
4. Loesch DZ, Huggins RM, Bui QM, Epstein JL, Taylor AK, Hagerman RJ: Effect of the deficits of fragile X mental retardation protein on cognitive status of fragile x males and females assessed by robust pedigree analysis. J Dev Behav Pediatr 2002, 23:416-423. (Pubitemid 36054485)
5. Loesch DZ, Huggins RM, Taylor AK: Application of robust pedigree analysis in studies of complex genotype-phenotype relationships in fragile X syndrome. Am J Med Genet 2002, 107:136-142. (Pubitemid 34038595)
6. Johnson AD, Newton-Cheh C, Chasman DI, Ehret GB, Johnson T, Rose L, Rice K, Verwoert GC, Launer LJ, Gudnason V, Larson MG, Chakravarti A, Psaty BM, Caulfield M, van Duijn CM, Ridker PM, Munroe PB, Levy D, Cohorts for Heart and Aging Research in Genomic Epidemiology Consortium; Global BPgen Consortium; Women's Genome Health Study: Association of hypertension drug target genes with blood pressure and hypertension in 86,588 individuals. Hypertension 2011, 57:903-910.
7. Glover M, Zuber AM, O'Shaughnessy KM: Hypertension, dietary salt intake, and the role of the thiazide-sensitive sodium chloride transporter NCCT. Cardiovasc Ther 2011, 29:68-76.
8. Ayalew M, Le-Niculescu H, Levey DF, Jain N, Changala B, Patel SD, Winiger E, Breier A, Shekhar A, Amdur R, Koller D, Nurnberger JI, Corvin A, Geyer M, Tsuang MT, Salomon D, Schork NJ, Fanous AH, O' Donovan MC, Niculescu AB: Convergent functional genomics of schizophrenia: from comprehensive understanding to genetic risk prediction. Mol Psychiatry 2012, 17: 887-905.
9. Davis LK, Hazlett HC, Librant AL, Nopoulos P, Sheffield VC, Piven J, Wassink TH: Cortical enlargement in autism is associated with a functional VNTR in the monoamine oxidase A gene. Am J Med Genet B Neuropsychiatr Genet 2008, 147B: 1145-1151.
10. Yoo HJ, Lee SK, Park M, Cho IH, Hyun SH, Lee JC, Yang SY, Kim SA: Family- and population-based association studies of monoamine oxidase A and autism spectrum disorders in Korean. Neurosci Res 2009, 63:172-176.
11. Tassone F, Qi L, Zhang W, Hansen RL, Pessah IN, Hertz-Picciotto I: MAOA, DBH, and SLC6A4 variants in CHARGE: a case-control study of autism spectrum disorders. Autism Res 2011, 4:250-261.
12. Bouma EM, Riese H, Doornbos B, Ormel J, Oldehinkel AJ: Genetically based reduced MAOA and COMT functioning is associated with the cortisol stress response: a replication study. Mol Psychiatry 2012, 17:119-121.
13. Kebir O, Joober R: Neuropsychological endophenotypes in attention-deficit/hyperactivity disorder: a review of genetic association studies. Eur Arch Psychiatry Clin Neurosci 2011, 261:583-594.
14. Dannlowski U, Ohrmann P, Konrad C, Domschke K, Bauer J, Kugel H, Hohoff C, Schoning S, Kersting A, Baune BT, Mortensen LS, Arolt V, Zwitserlood P, Deckert J, Heindel W, Suslow T: Reduced amygdala-prefrontal coupling in major depression: association with MAOA genotype and illness severity. Int J Neuropsychopharmacol 2009, 12:11-22.
15. Fergusson DM, Boden JM, Horwood LJ, Miller A, Kennedy MA: Moderating role of the MAOA genotype in antisocial behaviour. Br J Psychiatry 2012, 200:116-123.
16. Hazlett HC, Poe M, Gerig G, Smith RG, Provenzale J, Ross A, Gilmore J, Piven J: An MRI and head circumference study of brain size in autism: birth through age two years. Arch Gen Psychiatry 2005, 62:1366-1376. (Pubitemid 41746614)
17. Bailey DBJ, Mesibov GB, Hatton DD, Clark RD, Roberts JE, Mayhew L: Autistic behavior in young boys with fragile X syndrome. J Autism Dev Disord 1998, 28:499-508. (Pubitemid 29062059)
18. Hazlett HC, Poe MD, Lightbody AA, Gerig G, Macfall JR, Ross AK, Provenzale J, Martin A, Reiss AL, Piven J: Teasing apart the heterogeneity of autism: same behavior, different brains in toddlers with fragile X syndrome and autism. J Neurodev Disord 2009, 1:81-90.
19. Hazlett HC, Poe MD, Lightbody AA, Styner M, MacFall JR, Reiss AL, Piven J: Trajectories of early brain volume development in fragile X syndrome and autism. J Am Acad Child Adolesc Psychiatry 2012, 51:921-933.
20. Hoeft F, Lightbody AA, Hazlett HC, Patnaik S, Piven J, Reiss AL: Morphometric spatial patterns differentiating boys with fragile X syndrome, typically developing boys, and developmentally delayed boys aged 1 to 3 years. Arch Gen Psychiatry 2008, 65:1087-1097.
21. Hoeft F, Walter E, Lightbody AA, Hazlett HC, Chang C, Piven J, Reiss AL: Neuroanatomical differences in toddler boys with fragile x syndrome and idiopathic autism. Arch Gen Psychiatry 2011, 68:295-305.
22. Lord C, Rutter M, Le CA: Autism diagnostic interview-revised: a revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders. J Autism Dev Disord 1994, 24:659-685. (Pubitemid 24309810)
23. DiLavore PC, Lord C, Rutter M: The pre-linguistic autism diagnostic observation schedule. J Autism Dev Disorders 1995, 25:355-379.
24. Mullen EM: Mullen scales of early learning: AGS edition. Circle Pines, MN: American Guidance Service; 1995.
25. Sparrow SS, Balla D, Cicchetti D: Vineland adaptive behavior scales (survey form). Circle Pines, MN: American Guidance Service; 1984.
26. Andreasen NC, Cizadlo T, Harris G, Swayze V, O'Leary DS, Cohen G, Ehrhardt J, Yuh WT: Voxel processing techniques for the antemortem study of neuroanatomy and neuropathology using magnetic resonance imaging. J Neuropsychiatr Clin Neurosci 1993, 5: 121-130. (Pubitemid 23154524)
27. Andreasen NC, Cohen G, Harris G, Cizadlo T, Parkkinen J, Rezai K, Swayze VW: Image processing for the study of brain structure and function: problems and programs. J Neuropsychiatr Clin Neurosci 1992, 4:125-133.
28. Andreasen NC, Tamminga CA: Images in neuroscience: cortex. II: identifying lobes and landmarks. Am J Psychiatr 1994, 151:1722.
29. Cohen G, Andreasen NC, Alliger R, Arndt S, Kuan J, Yuh WTC, Ehrhardt J: Segmentation techniques for the classification of brain tissue using magnetic resonance imaging. Psychiatry Res Neuroimaging 1992, 45:33-51.
30. Magnotta VA, Harris G, Andreasen NC, O'Leary DS, Yuh WT, Heckel D: Structural MR image processing using the BRAINS2 toolbox. Comput Med Imaging Graph 2002, 26:251-264. (Pubitemid 34628869)
31. Talairach J, Tournoux P: Co-planar stereotaxic atlas of the human brain. New York, NY: Thieme; 1988.
32. Van Leemput K, Maes F, Vandermeulen D, Suetens P: Automated model-based bias field correction of MR images of the brain. IEEE Trans Med Imaging 1999, 18:885-896. (Pubitemid 32211104)
33. Sabol SZ, Hu S, Hamer D: A functional polymorphism in the monoamine oxidase A gene promoter. Hum Genet 1998, 103:273-279. (Pubitemid 28470076)
34. Bonnin A, Levitt P: Fetal, maternal, and placental sources of serotonin and new implications for developmental programming of the brain. Neuroscience 2011, 197:1-7.
35. Deneris ES: Molecular genetics of mouse serotonin neurons across the lifespan. Neuroscience 2011, 197: 17-27.
36. Abramson RK, Wright HH, Carpenter R, Brennan W, Lumpuy O, Cole E, Young SR: Elevated blood serotonin in autistic probands and their first-degree relatives. J Autism Dev Disord 1989, 19:397-407. (Pubitemid 19233511)
37. Devlin B, Cook EH Jr, Coon H, Dawson G, Grigorenko EL, McMahon W, Minshew N, Pauls D, Smith M, Spence MA, Rodier PM, Stodgell C, Schellenberg GD, CPEA Genetics Network: Autism and the serotonin transporter: the long and short of it. Mol Psychiatry 2005, 10:1110-1116. (Pubitemid 43251101)
38. Herault J, Petit E, Martineau J, Cherpi C, Perrot A, Barthelemy C, Lelord G, Muh JP: Serotonin and autism: biochemical and molecular biology features. Psychiatry Res 1996, 65:33-43. (Pubitemid 26391623)
39. Piven J, Tsai GC, Nehme E, Coyle JT, Chase GA, Folstein SE: Platelet serotonin, a possible marker for familial autism. J Autism Dev Disord 1991, 21:51-59.
40. Whitaker-Azmitia PM: Serotonin and brain development: role in human developmental diseases. Brain Res Bull 2001, 56:479-485.
41. Jonsson EG, Norton N, Gustavsson JP, Oreland L, Owen MJ, Sedvall GC: A promoter polymorphism in the monoamine oxidase A gene and its relationships to monoamine metabolite concentrations in CSF of healthy volunteers. J Psychiatr Res 2000, 34:239-244. (Pubitemid 30364924)
42. Williams RB, Marchuk DA, Gadde KM, Barefoot JC, Grichnik K, Helms MJ, Kuhn CM, Lewis JG, Schanberg SM, Stafford-Smith M, Suarez EC, Clary GL, Svenson IK, Siegler IC: Serotonin-related gene polymorphisms and central nervous system serotonin function. Neuropsychopharmacology 2003, 28:533-541.
43. Zalsman G, Huang YY, Harkavy-Friedman JM, Oquendo MA, Ellis SP, Mann JJ: Relationship of MAO-a promoter (u-VNTR) and COMT (V158M) gene polymorphisms to CSF monoamine metabolites levels in a psychiatric sample of caucasians: a preliminary report. Am J Med Genet B Neuropsychiatr Genet 2005, 132:100-103. (Pubitemid 40066205)
44. Ducci F, Newman TK, Funt S, Brown GL, Virkkunen M, Goldman D: A functional polymorphism in the MAOA gene promoter (MAOA-LPR) predicts central dopamine function and body mass index. Mol Psychiatry 2006, 11:858-866. (Pubitemid 44299107)
45. Dickinson JL, Sale MM, Passmore A, FitzGerald LM, Wheatley CM, Burdon KP, Craig JE, Tengtrisorn S, Carden SM, Maclean H, Mackey DA: Mutations in the NDP gene: contribution to Norrie disease, familial exudative vitreoretinopathy and retinopathy of prematurity. Clin Experiment Ophthalmol 2006, 34:682-688. (Pubitemid 44363620)
46. Halpin C, Owen G, Gutierrez-Espeleta GA, Sims K, Rehm HL: Audiologic features of Norrie disease. Ann Otol Rhinol Laryngol 2005, 114:533-538. (Pubitemid 40995037)
47. Brunner HG, Nelen M, Breakefield XO, Ropers HH, van Oost BA: Abnormal behavior associated with a point mutation in the structural gene for monoamine oxidase A. Science 1993, 262:578-580. (Pubitemid 23350673)
48. Brunner HG, Nelen MR, van Zandvoort P, Abeling NG, van Gennip AH, Wolters EC, Kuiper MA, Ropers HH, van Oost BA: X-linked borderline mental retardation with prominent behavioral disturbance: phenotype, genetic localization, and evidence for disturbed monoamine metabolism. Am J Hum Genet 1993, 52:1032-1039. (Pubitemid 23311342)
49. Zhang H, Smith GN, Liu X, Holden JJ: Association of MAOA, 5-HTT, and NET promoter polymorphisms with gene expression and protein activity in human placentas. Physiol Genomics 2010, 42:85-92.
50. Deckert J, Catalano M, Syagailo YV, Bosi M, Okladnova O, Di Bella D, Nothen MM, Maffei P, Franke P, Fritze J, Maier W, Propping P, Beckmann H, Bellodi L, Lesch KP: Excess of high activity monoamine oxidase A gene promoter alleles in female patients with panic disorder. Hum Mol Genet 1999, 8:621-624. (Pubitemid 29139976)
51. Beitchman JH, Mik HM, Ehtesham S, Douglas L, Kennedy JL: MAOA and persistent, pervasive childhood aggression. Mol Psychiatry 2004, 9:546-547.
52. Fan M, Liu B, Jiang T, Jiang X, Zhao H, Zhang J: Meta-analysis of the association between the monoamine oxidase-A gene and mood disorders. Psychiatr Genet 2010, 20:1-7.
53. Nordquist N, Oreland L: Serotonin, genetic variability, behaviour, and psychiatric disorders - a review. Ups J Med Sci 2010, 115:2-10.
54. Cohen IL, Liu X, Schutz C, White BN, Jenkins EC, Brown WT, Holden JJ: Association of autism severity with a monoamine oxidase A functional polymorphism. Clin Genet 2003, 64:190-197. (Pubitemid 37069450)
55. Cohen IL, Liu X, Lewis ME, Chudley A, Forster-Gibson C, Gonzalez M, Jenkins EC, Brown WT, Holden JJ: Autism severity is associated with child and maternal MAOA genotypes. Clin Genet 2011, 79:355-362.
56. Lainhart JE, Piven J, Wzorek M, Landa R, Santangelo SL, Coon H, Folstein SE: Macrocephaly in children and adults with autism. J Am Acad Child Adolesc Psychiatry 1997, 36:282-290. (Pubitemid 27049578)
57. Wassink TH, Hazlett HC, Epping EA, Arndt S, Dager SR, Schellenberg GD, Dawson G, Piven J: Cerebral cortical gray matter overgrowth and functional variation of the serotonin transporter gene in autism. Arch Gen Psychiatry 2007, 64:709-717. (Pubitemid 46878671)
58. Bradley SL, Dodelzon K, Sandhu HK, Philibert RA: Relationship of serotonin transporter gene polymorphisms and haplotypes to mRNA transcription. Am J Med Genet B Neuropsychiatr Genet 2005, 136:58-61. (Pubitemid 40917529)
59. Moy SS, Nadler JJ, Perez A, Barbaro RP, Johns JM, Magnuson TR, Piven J, Crawley JN: Sociability and preference for social novelty in five inbred strains: an approach to assess autistic-like behavior in mice. Genes Brain Behav 2004, 3:287-302. (Pubitemid 39277416)
60. Moy SS, Nadler JJ, Young NB, Perez A, Holloway LP, Barbaro RP, Barbaro JR, Wilson LM, Threadgill DW, Lauder JM, Magnuson TR, Crawley JN: Mouse behavioral tasks relevant to autism: phenotypes of 10 inbred strains. Behav Brain Res 2007, 176:4-20. (Pubitemid 44879623)
61. Moy SS, Nadler JJ, Young NB, Nonneman RJ, Grossman AW, Murphy DL, D'Ercole AJ, Crawley JN, Magnuson TR, Lauder JM: Social approach in genetically engineered mouse lines relevant to autism. Genes Brain Behav 2009, 8:129-142.
62. Page DT, Kuti OJ, Prestia C, Sur M: Haploinsufficiency for pten and serotonin transporter cooperatively influences brain size and social behavior. Proc Natl Acad Sci U S A 2009, 106:1989-1994.